New Meningitis Vaccine Available Monday, May 2, 2016
On Monday, May 2, 2016, we will begin administering the Trumenba vaccine. This vaccine protects against a form of bacterial meningitis called Meningococcus type B, or MenB for short. Menactra, which we give at ages 11 and 16, protects against the A, C, W and Y forms of bacterial meningitis, but not type B. We are recommending Trumenba for all teens aged 16 and up. Below are more details.
- It is a 3 dose vaccine. It is given at 0, 2 and 6 months increments.
- It is covered by all insurance companies.
- It is given to teens 16 years old and up.
- It covers only the B type strain so the Menactra vaccine will still need to be given.
- It is not a live vaccine.
- It does not contain any preservatives or thimerosal.
- For teens that are going off to college, if the series is not complete before they graduate, they can come back and complete the series at our office.
- It is a latex free vaccine.
The vaccine series can be started at your child’s next annual check up, or you can call to make a shot visit appointment with one of the nurses. Please call (804) 282-4205 during our regular business hours to speak with someone about scheduling a visit.
For more background information and FAQs about Trumenba, visit the Trumenba page in our Resource Library.